These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 10603389)

  • 41. Immunogenicity of a Salmonella typhimurium aroA aroD vaccine expressing a nontoxic domain of Clostridium difficile toxin A.
    Ward SJ; Douce G; Figueiredo D; Dougan G; Wren BW
    Infect Immun; 1999 May; 67(5):2145-52. PubMed ID: 10225867
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mucosal immunization with attenuated Salmonella enterica serovar Typhi expressing protective antigen of anthrax toxin (PA83) primes monkeys for accelerated serum antibody responses to parenteral PA83 vaccine.
    Galen JE; Chinchilla M; Pasetti MF; Wang JY; Zhao L; Arciniega-Martinez I; Silverman DJ; Levine MM
    J Infect Dis; 2009 Feb; 199(3):326-35. PubMed ID: 19099487
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Towards a human oral vaccine for anthrax: the utility of a Salmonella Typhi Ty21a-based prime-boost immunization strategy.
    Baillie LW; Rodriguez AL; Moore S; Atkins HS; Feng C; Nataro JP; Pasetti MF
    Vaccine; 2008 Nov; 26(48):6083-91. PubMed ID: 18805452
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Safety of live oral Salmonella typhi vaccine strains with deletions in htrA and aroC aroD and immune response in humans.
    Tacket CO; Sztein MB; Losonsky GA; Wasserman SS; Nataro JP; Edelman R; Pickard D; Dougan G; Chatfield SN; Levine MM
    Infect Immun; 1997 Feb; 65(2):452-6. PubMed ID: 9009296
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A Phase I, dose-escalation trial in adults of three recombinant attenuated Salmonella Typhi vaccine vectors producing Streptococcus pneumoniae surface protein antigen PspA.
    Frey SE; Lottenbach KR; Hill H; Blevins TP; Yu Y; Zhang Y; Brenneman KE; Kelly-Aehle SM; McDonald C; Jansen A; Curtiss R
    Vaccine; 2013 Oct; 31(42):4874-80. PubMed ID: 23916987
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prophylactic potential of cytolethal distending toxin B (CdtB) subunit of typhoid toxin against Typhoid fever.
    Thakur R; Pathania P; Kaur N; Joshi V; Kondepudi KK; Suri CR; Rishi P
    Sci Rep; 2019 Dec; 9(1):18404. PubMed ID: 31804525
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Helicobacter pylori infection affects immune responses following vaccination of typhoid-naive U.S. adults with attenuated Salmonella typhi oral vaccine CVD 908-htrA.
    Muhsen K; Pasetti MF; Reymann MK; Graham DY; Levine MM
    J Infect Dis; 2014 May; 209(9):1452-8. PubMed ID: 24273182
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Salmonella enterica serovar Typhimurium strain lacking pmrG-HM-D provides excellent protection against salmonellosis in murine typhoid model.
    Negi VD; Singhamahapatra S; Chakravortty D
    Vaccine; 2007 Jul; 25(29):5315-23. PubMed ID: 17574312
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of murine nasal-associated lymphoid tissue and Peyer's patches.
    Heritage PL; Underdown BJ; Arsenault AL; Snider DP; McDermott MR
    Am J Respir Crit Care Med; 1997 Oct; 156(4 Pt 1):1256-62. PubMed ID: 9351630
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Live oral typhoid vaccine Ty21a induces cross-reactive humoral immune responses against Salmonella enterica serovar Paratyphi A and S. Paratyphi B in humans.
    Wahid R; Simon R; Zafar SJ; Levine MM; Sztein MB
    Clin Vaccine Immunol; 2012 Jun; 19(6):825-34. PubMed ID: 22492745
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Specific lung mucosal and systemic immune responses after oral immunization of mice with Salmonella typhimurium aroA, Salmonella typhi Ty21a, and invasive Escherichia coli expressing recombinant pertussis toxin S1 subunit.
    Walker MJ; Rohde M; Timmis KN; Guzmán CA
    Infect Immun; 1992 Oct; 60(10):4260-8. PubMed ID: 1398937
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of preexisting immunity to Salmonella on the immune response to recombinant Salmonella enterica serovar typhimurium expressing a Porphyromonas gingivalis hemagglutinin.
    Kohler JJ; Pathangey LB; Gillespie SR; Brown TA
    Infect Immun; 2000 Jun; 68(6):3116-20. PubMed ID: 10816452
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cellular immunity against Salmonella typhi after live oral vaccine.
    Tagliabue A; Nencioni L; Caffarena A; Villa L; Boraschi D; Cazzola G; Cavalieri S
    Clin Exp Immunol; 1985 Nov; 62(2):242-7. PubMed ID: 3878744
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The development of oral vaccines against parasitic diseases utilizing live attenuated Salmonella.
    Chatfield SN; Roberts M; Dougan G; Hormaeche C; Khan CM
    Parasitology; 1995; 110 Suppl():S17-24. PubMed ID: 7784125
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transcutaneous Vaccination with Conjugate Typhoid Vaccine Vi-DT Induces Systemic, Mucosal, and Memory Anti-Polysaccharide Responses.
    Bhuiyan MS; Kalsy A; Arifuzzaman M; Charles RC; Harris JB; Calderwood SB; Qadri F; Ryan ET
    Am J Trop Med Hyg; 2020 Sep; 103(3):1032-1038. PubMed ID: 32720632
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Safety and immunogenicity of phoP/phoQ-deleted Salmonella typhi expressing Helicobacter pylori urease in adult volunteers.
    DiPetrillo MD; Tibbetts T; Kleanthous H; Killeen KP; Hohmann EL
    Vaccine; 1999 Oct; 18(5-6):449-59. PubMed ID: 10519934
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Host and bacterial factors affecting induction of immune responses to flagellin expressed by attenuated Salmonella vaccine strains.
    Sbrogio-Almeida ME; Mosca T; Massis LM; Abrahamsohn IA; Ferreira LC
    Infect Immun; 2004 May; 72(5):2546-55. PubMed ID: 15102762
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Salmonella Typhi outer membrane protein STIV is a potential candidate for vaccine development against typhoid and paratyphoid fever.
    Das S; Chowdhury R; Pal A; Okamoto K; Das S
    Immunobiology; 2019 May; 224(3):371-382. PubMed ID: 30952553
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Recombinant Salmonella enterica serovar Typhi in a prime-boost strategy.
    Vindurampulle CJ; Cuberos LF; Barry EM; Pasetti MF; Levine MM
    Vaccine; 2004 Sep; 22(27-28):3744-50. PubMed ID: 15315855
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A new intra-NALT route elicits mucosal and systemic immunity against Moraxella catarrhalis in a mouse challenge model.
    Hou Y; Hu WG; Hirano T; Gu XX
    Vaccine; 2002 May; 20(17-18):2375-81. PubMed ID: 12009294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.